Literature DB >> 17624684

Modic changes, possible causes and relation to low back pain.

H B Albert1, P Kjaer, T S Jensen, J S Sorensen, T Bendix, Claus Manniche.   

Abstract

UNLABELLED: In patients with low back pain (LBP) it is only possible to diagnose a small proportion, (approximately 20%), on a patho-anatomical basis. Therefore, the identification of relevant LBP subgroups, preferably on a patho-anatomical basis, is strongly needed. Signal changes on MRI in the vertebral body marrow adjacent to the end plates also known as Modic changes (MC) are common in patients with LBP (18-58%) and is strongly associated with LBP. In asymptomatic persons the prevalence is 12-13%. MC are divided into three different types. Type 1 consists of fibro vascular tissue, type 2 is yellow fat, and type 3 is sclerotic bone. The temporal evolution of MC is uncertain, but the time span is years. Subchondral bone marrow signal changes associated with pain can be observed in different specific infectious, degenerative and immunological diseases such as osseous infections, osteoarthritis, ankylosing spondylitis and spondylarthritis. In the vertebrae, MC is seen in relation to vertebral fractures, spondylodiscitis, disc herniation, severe disc degeneration, injections with chymopapain, and acute Schmorl's impressions. The aim of this paper is to propose two possible pathogenetic mechanisms causing Modic changes. These are: A mechanical cause: Degeneration of the disc causes loss of soft nuclear material, reduced disc height and hydrostatic pressure, which increases the shear forces on the endplates and micro fractures may occur. The observed MC could represent oedema secondary to the fracture and subsequent inflammation, or a result of an inflammatory process from a toxic stimulus from the nucleus pulposus that seeps through the fractures. A bacterial cause: Following a tear in the outer fibres of the annulus e.g. disc herniation, new capilarisation and inflammation develop around the extruded nuclear material. Through this tissue it is possible for anaerobic bacteria to enter the anaerobic disc and in this environment cause a slowly developing low virulent infection. The MC could be the visible signs of the inflammation and oedema surrounding this infection, because the anaerobic bacteria cannot thrive in the highly aerobic environment of the MC type 1. PERSPECTIVES: One or both of the described mechanisms can - if proven - be of significant importance for this specific subgroup of patients with LBP. Hence, it would be possible to give a more precise and relevant diagnosis to 20-50% of patients with LBP and enable in the development of efficient treatments which might be antibiotics, special rehabilitation programmes, rest, stabilizing exercise, or surgical fixation, depending on the underlying cause for the MC.

Entities:  

Mesh:

Year:  2007        PMID: 17624684     DOI: 10.1016/j.mehy.2007.05.014

Source DB:  PubMed          Journal:  Med Hypotheses        ISSN: 0306-9877            Impact factor:   1.538


  101 in total

1.  Intervertebral disc penetration by antibiotics used prophylactically in spinal surgery: implications for the current standards and treatment of disc infections.

Authors:  Manu N Capoor; Jan Lochman; Andrew McDowell; Jonathan E Schmitz; Martin Solansky; Martina Zapletalova; Todd F Alamin; Michael F Coscia; Steven R Garfin; Radim Jancalek; Filip Ruzicka; A Nick Shamie; Martin Smrcka; Jeffrey C Wang; Christof Birkenmaier; Ondrej Slaby
Journal:  Eur Spine J       Date:  2018-12-01       Impact factor: 3.134

2.  Propionibacterium acnes induces discogenic low back pain via stimulating nucleus pulposus cells to secrete pro-algesic factor of IL-8/CINC-1 through TLR2-NF-κB p65 pathway.

Authors:  Yucheng Jiao; Ye Yuan; Yazhou Lin; Zezhu Zhou; Yuehuan Zheng; Wenjian Wu; Guoqing Tang; Yong Chen; Jiaqi Xiao; Changwei Li; Zhe Chen; Peng Cao
Journal:  J Mol Med (Berl)       Date:  2018-11-06       Impact factor: 4.599

3.  Relationship of Modic type 1 change with disc degeneration: a prospective MRI study.

Authors:  Katariina Luoma; Tapio Vehmas; Mats Grönblad; Liisa Kerttula; Eeva Kääpä
Journal:  Skeletal Radiol       Date:  2008-12-19       Impact factor: 2.199

4.  Association between chronic inflammation and latent infection of Propionibacterium acnes in non-pyogenic degenerated intervertebral discs: a pilot study.

Authors:  Ye Yuan; Yong Chen; Zezhu Zhou; Yucheng Jiao; Changwei Li; Yuehuan Zheng; Yazhou Lin; Jiaqi Xiao; Zhe Chen; Peng Cao
Journal:  Eur Spine J       Date:  2017-10-31       Impact factor: 3.134

Review 5.  Pathobiology of Modic changes.

Authors:  Stefan Dudli; Aaron J Fields; Dino Samartzis; Jaro Karppinen; Jeffrey C Lotz
Journal:  Eur Spine J       Date:  2016-02-25       Impact factor: 3.134

Review 6.  Vertebral endplate signal changes (Modic change): a systematic literature review of prevalence and association with non-specific low back pain.

Authors:  Tue Secher Jensen; Jaro Karppinen; Joan S Sorensen; Jaakko Niinimäki; Charlotte Leboeuf-Yde
Journal:  Eur Spine J       Date:  2008-09-12       Impact factor: 3.134

Review 7.  Modic changes: a systematic review of the literature.

Authors:  Yue-Hui Zhang; Chang-Qing Zhao; Lei-Sheng Jiang; Xiao-Dong Chen; Li-Yang Dai
Journal:  Eur Spine J       Date:  2008-08-27       Impact factor: 3.134

Review 8.  Disc in flames: Roles of TNF-α and IL-1β in intervertebral disc degeneration.

Authors:  Z I Johnson; Z R Schoepflin; H Choi; I M Shapiro; M V Risbud
Journal:  Eur Cell Mater       Date:  2015-09-21       Impact factor: 3.942

9.  Structural vertebral endplate nomenclature and etiology: a study by the ISSLS Spinal Phenotype Focus Group.

Authors:  Uruj Zehra; Cora Bow; Jeffrey C Lotz; Frances M K Williams; S Rajasekaran; Jaro Karppinen; Keith D K Luk; Michele C Battiê; Dino Samartzis
Journal:  Eur Spine J       Date:  2017-09-12       Impact factor: 3.134

10.  Modic type I changes and recovery of back pain after lumbar microdiscectomy.

Authors:  Andreas Sørlie; Viggo Moholdt; Kjell Arne Kvistad; Øystein P Nygaard; Tor Ingebrigtsen; Trond Iversen; Roar Kloster; Tore K Solberg
Journal:  Eur Spine J       Date:  2012-07-29       Impact factor: 3.134

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.